NCT07420465 Cardiometabolic Risk in Pregnancy and Postpartum
| NCT ID | NCT07420465 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Forgive Avorgbedor |
| Condition | Hypertensive Disorders of Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-06-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-04-01 with a primary completion date of 2027-06-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate changes in blood pressure and early cardiovascular risk markers and to determine whether a postpartum education intervention can improve cardiovascular risk monitoring among pregnant women in their third trimester through six months postpartum in Accra, Ghana. The study includes women aged 18 years and older with and without pregnancy-related cardiometabolic complications. Findings from this study will inform the development of scalable postpartum screening and intervention strategies to reduce long-term cardiovascular disease risk among women.
Eligibility Criteria
Inclusion Criteria: * Singleton pregnancy * 18 years and older * 3rd trimester of pregnancy at enrollment * Will be living in the area for the study duration * Women with or without pregnancy complications (e.g., gestational hypertension, preeclampsia, gestational diabetes) Exclusion Criteria: * Multiple births * Diagnosed CVD or diabetes prior to pregnancy * Renal or other serious maternal diseases pre-pregnancy
Contact & Investigator
Samuel Dery, PhD
STUDY DIRECTOR
University of Ghana
Frequently Asked Questions
Who can join the NCT07420465 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Hypertensive Disorders of Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07420465 currently recruiting?
Yes, NCT07420465 is actively recruiting participants. Contact the research team at f-avorgbedo@uncg.edu for enrollment information.
Where is the NCT07420465 trial being conducted?
This trial is being conducted at Accra, Ghana.
Who is sponsoring the NCT07420465 clinical trial?
NCT07420465 is sponsored by Forgive Avorgbedor. The principal investigator is Samuel Dery, PhD at University of Ghana. The trial plans to enroll 200 participants.